GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call

Rhea-AI Summary

GoodRx Holdings, Inc. will release its Q3 2023 financial results on November 9, 2023.

Positive

• GoodRx will release its Q3 2023 financial results on November 9, 2023.

Negative

• None.

SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, today announced it will release its third quarter 2023 financial results before U.S. markets open on Thursday, November 9, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company’s investor relations website at https://investors.goodrx.com, where accompanying materials will be posted prior to the conference call.

Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company’s investor relations website at https://investors.goodrx.com for at least 30 days.

About GoodRx

GoodRx is a leading resource for healthcare savings and information that makes healthcare affordable and convenient for all Americans. We offer consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. Since 2011, we have helped consumers save over $60 billion and are one of the most downloaded medical apps over the past decade.

GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231012336216/en/

Investor Contact

GoodRx

Whitney Notaro

wnotaro@goodrx.com

Press Contact

GoodRx

Lauren Casparis

lcasparis@goodrx.com

Source: GoodRx Holdings, Inc.

FAQ

When will GoodRx release its Q3 2023 financial results?

GoodRx will release its Q3 2023 financial results on November 9, 2023.

What time is the conference call and webcast?

The conference call and webcast will be held at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time).

Where can I access the conference call?

You can access the conference call by pre-registering using the provided link.

Will the webcast be available after the live call?

Yes, an archived version of the webcast will be available on GoodRx's investor relations website for at least 30 days.